Summary
From funding and investment hurdles, to the changing regulatory landscape, new legislation, and intellectual property strategies, the medical device sector, like many others in life sciences, will continue to face unique business and product development challenges in 2010. During this recent breakfast program hosted by BIOCOM and Goodwin Procter, partner Raymond Zemlin paired with key industry and investor participants for three mini panel discussions: The Medical Device Investment Market, Regulatory Issues and Developments at the FDA, and Monetizing Intellectual Property.
Speakers
- /en/people/z/zemlin-raymond
Raymond C. Zemlin
PartnerRetired Partner